CIK 0001855485 · <br>Emerging growth company
Calidi Biotherapeutics, Inc.
Sign in to watch- Tickers
- CLDI CLDWW
- Exchange
- NYSE, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862967193
- Phone
- 858-794-9600
- Business address
- 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.
Securities
- CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
- CLDWW Common stock OTC
- CORRESP Other Correspondence Between Filers and SEC Staff
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- DRS Other Draft Registration Statement
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Auditor change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Executive or director change · Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Unregistered share sale · Other events
Page 5 of 21 · 406 filings